메뉴 건너뛰기




Volumn 2012, Issue , 2012, Pages

Engineered T cells for the adoptive therapy of b-cell chronic lymphocytic leukaemia

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD134 ANTIGEN; CD137 ANTIGEN; CD19 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CHIMERIC ANTIGEN RECEPTOR; CHIMERIC PROTEIN; CYCLOPHOSPHAMIDE; FLUDARABINE; GAMMA INTERFERON; INTERLEUKIN 2; LYMPHOCYTE ANTIGEN RECEPTOR; RECEPTOR; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR 1; RECOMBINANT RECEPTOR; UNCLASSIFIED DRUG;

EID: 80053547456     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2012/595060     Document Type: Review
Times cited : (22)

References (78)
  • 4
    • 2642551675 scopus 로고    scopus 로고
    • Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: Implications of minimal residual disease measurement with quantitative PCR
    • DOI 10.1182/blood-2003-12-4321
    • Ritgen M., Stilgenbauer S., von Neuhoff N., Humpe A., Brggemann M., Pott C., Raff T., Krber A., Bunjes D., Schlenk R., Schmitz N., Dhner H., Kneba M., Dreger P., Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR Blood 2004 104 8 2600 2602 (Pubitemid 39331866)
    • (2004) Blood , vol.104 , Issue.8 , pp. 2600-2602
    • Ritgen, M.1    Stilgenbauer, S.2    Von Neuhoff, N.3    Humpe, A.4    Bruggemann, M.5    Pott, C.6    Raff, T.7    Krober, A.8    Bunjes, D.9    Schlenk, R.10    Schmitz, N.11    Dohner, H.12    Kneba, M.13    Dreger, P.14
  • 5
    • 1642292996 scopus 로고    scopus 로고
    • H gene mutational status
    • DOI 10.1182/blood-2003-05-1549
    • Dreger P., Stilgenbauer S., Benner A., Ritgen M., Krber A., Kneba M., Schmitz N., Dhner H., The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the V H gene mutational status Blood 2004 103 7 2850 2858 (Pubitemid 38393051)
    • (2004) Blood , vol.103 , Issue.7 , pp. 2850-2858
    • Dreger, P.1    Stilgenbauer, S.2    Benner, A.3    Ritgen, M.4    Krober, A.5    Kneba, M.6    Schmitz, N.7    Dohner, H.8
  • 7
    • 33748694108 scopus 로고    scopus 로고
    • Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemia
    • DOI 10.1182/blood-2006-04-007898
    • Zenz T., Ritgen M., Dreger P., Krber A., Barth T. F., Schlenk R., Bttcher S., Hallek M. J., Kneba M., Bunjes D., Dhner H., Stilgenbauer S., Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemia Blood 2006 108 6 2127 2130 (Pubitemid 44395031)
    • (2006) Blood , vol.108 , Issue.6 , pp. 2127-2130
    • Zenz, T.1    Ritgen, M.2    Dreger, P.3    Krober, A.4    Barth, T.F.5    Schlenk, R.6    Bottcher, S.7    Hallek, M.J.8    Kneba, M.9    Bunjes, D.10    Dohner, H.11    Stilgenbauer, S.12
  • 8
    • 78650007259 scopus 로고    scopus 로고
    • State of the art treatment of chronic lymphocytic leukaemia
    • Hallek M., Pflug N., State of the art treatment of chronic lymphocytic leukaemia Blood Reviews 2011 25 1 1 9
    • (2011) Blood Reviews , vol.25 , Issue.1 , pp. 1-9
    • Hallek, M.1    Pflug, N.2
  • 9
    • 41149101246 scopus 로고    scopus 로고
    • Antibody Therapy for Chronic Lymphocytic Leukemia
    • DOI 10.1053/j.seminhematol.2008.02.001, PII S0037196308000024
    • Christian B. A., Lin T. S., Antibody therapy for chronic lymphocytic leukemia Seminars in Hematology 2008 45 2 95 103 (Pubitemid 351434408)
    • (2008) Seminars in Hematology , vol.45 , Issue.2 , pp. 95-103
    • Christian, B.A.1    Lin, T.S.2
  • 12
    • 68049102310 scopus 로고    scopus 로고
    • Development of tumor-reactive T-cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia
    • Nishida T., Hudecek M., Kostic A., Bleakley M., Warren E. H., Maloney D., Storb R., Riddell S. R., Development of tumor-reactive T-cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia Clinical Cancer Research 2009 15 14 4759 4768
    • (2009) Clinical Cancer Research , vol.15 , Issue.14 , pp. 4759-4768
    • Nishida, T.1    Hudecek, M.2    Kostic, A.3    Bleakley, M.4    Warren, E.H.5    Maloney, D.6    Storb, R.7    Riddell, S.R.8
  • 13
    • 0036570957 scopus 로고    scopus 로고
    • Tuning tumor-specific T-cell activation: A matter of costimulation?
    • DOI 10.1016/S1471-4906(02)02180-4, PII S1471490602021804
    • Abken H., Hombach A., Heuser C., Kronfeld K., Seliger B., Tuning tumor-specific T-cell activation: a matter of costimulation? Trends in Immunology 2002 23 5 240 245 (Pubitemid 34499560)
    • (2002) Trends in Immunology , vol.23 , Issue.5 , pp. 240-245
    • Abken, H.1    Hombach, A.2    Heuser, C.3    Kronfeld, K.4    Seliger, B.5
  • 14
    • 0027471898 scopus 로고
    • Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ or ζ subunits of the immunoglobulin and T-cell receptors
    • DOI 10.1073/pnas.90.2.720
    • Eshhar Z., Waks T., Gross G., Schindler D. G., Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the or subunits of the immunoglobulin and T-cell receptors Proceedings of the National Academy of Sciences of the United States of America 1993 90 2 720 724 (Pubitemid 23028937)
    • (1993) Proceedings of the National Academy of Sciences of the United States of America , vol.90 , Issue.2 , pp. 720-724
    • Eshhar, Z.1    Waks, T.2    Gross, G.3    Schindler, D.G.4
  • 15
    • 0036635506 scopus 로고    scopus 로고
    • T-cell-receptor gene therapy
    • Schumacher T. N. M., T-cell-receptor gene therapy Nature Reviews Immunology 2002 2 7 512 519 (Pubitemid 37328742)
    • (2002) Nature Reviews Immunology , vol.2 , Issue.7 , pp. 512-519
    • Schumacher, T.N.M.1
  • 16
    • 0024834988 scopus 로고
    • Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity
    • DOI 10.1073/pnas.86.24.10024
    • Gross G., Waks T., Eshhar Z., Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity Proceedings of the National Academy of Sciences of the United States of America 1989 86 24 10024 10028 (Pubitemid 20030768)
    • (1989) Proceedings of the National Academy of Sciences of the United States of America , vol.86 , Issue.24 , pp. 10024-10028
    • Gross, G.1    Waks, T.2    Eshhar, Z.3
  • 17
    • 0029891157 scopus 로고    scopus 로고
    • Qualitative and quantitative contributions of the T cell receptor ζ chain to mature T cell apoptosis
    • DOI 10.1084/jem.183.5.2109
    • Combadire B., Freedman M., Chen L., Shores E. W., Love P., Lenardo M. J., Qualitative and quantitative contributions of the T-cell receptor chain to mature T-cell apoptosis Journal of Experimental Medicine 1996 183 5 2109 2117 (Pubitemid 26158903)
    • (1996) Journal of Experimental Medicine , vol.183 , Issue.5 , pp. 2109-2117
    • Combadiere, B.1    Freedman, M.2    Chen, L.3    Shores, E.W.4    Love, P.5    Lenardo, M.J.6
  • 18
    • 77957756405 scopus 로고    scopus 로고
    • Adoptive transfer of syngeneic T-cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B-cells
    • Kochenderfer J. N., Yu Z., Frasheri D., Restifo N. P., Rosenberg S. A., Adoptive transfer of syngeneic T-cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B-cells Blood 2010 116 19 3875 3886
    • (2010) Blood , vol.116 , Issue.19 , pp. 3875-3886
    • Kochenderfer, J.N.1    Yu, Z.2    Frasheri, D.3    Restifo, N.P.4    Rosenberg, S.A.5
  • 19
    • 76749120309 scopus 로고    scopus 로고
    • A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity
    • Zhao Y., Wang Q. J., Yang S., Kochenderfer J. N., Zheng Z., Zhong X., Sadelain M., Eshhar Z., Rosenberg S. A., Morgan R. A., A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity Journal of Immunology 2009 183 9 5563 5574
    • (2009) Journal of Immunology , vol.183 , Issue.9 , pp. 5563-5574
    • Zhao, Y.1    Wang, Q.J.2    Yang, S.3    Kochenderfer, J.N.4    Zheng, Z.5    Zhong, X.6    Sadelain, M.7    Eshhar, Z.8    Rosenberg, S.A.9    Morgan, R.A.10
  • 20
    • 51049104493 scopus 로고    scopus 로고
    • Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts
    • Klechevsky E., Gallegos M., Denkberg G., Palucka K., Banchereau J., Cohen C., Reiter Y., Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts Cancer Research 2008 68 15 6360 6367
    • (2008) Cancer Research , vol.68 , Issue.15 , pp. 6360-6367
    • Klechevsky, E.1    Gallegos, M.2    Denkberg, G.3    Palucka, K.4    Banchereau, J.5    Cohen, C.6    Reiter, Y.7
  • 21
    • 20444377728 scopus 로고    scopus 로고
    • T cell retargeting with MHC class I-restricted antibodies: The CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production
    • Willemsen R. A., Ronteltap C., Chames P., Debets R., Bolhuis R. L. H., T cell retargeting with MHC class I-restricted antibodies: the CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production Journal of Immunology 2005 174 12 7853 7858 (Pubitemid 40806294)
    • (2005) Journal of Immunology , vol.174 , Issue.12 , pp. 7853-7858
    • Willemsen, R.A.1    Ronteltap, C.2    Chames, P.3    Debets, R.4    Bolhuis, R.L.H.5
  • 25
    • 0032531091 scopus 로고    scopus 로고
    • Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product
    • Finney H. M., Lawson A. D. G., Bebbington C. R., Weir A. N. C., Chimeric receptors providing both primary and costimulatory signaling in T-cells from a single gene product Journal of Immunology 1998 161 6 2791 2797 (Pubitemid 28425698)
    • (1998) Journal of Immunology , vol.161 , Issue.6 , pp. 2791-2797
    • Finney, H.M.1    Lawson, A.D.G.2    Bebbington, C.R.3    Weir, A.N.C.4
  • 26
    • 0035576250 scopus 로고    scopus 로고
    • Tumor-specific T cell activation by recombinant immunoreceptors: CD3ζ signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3ζ signaling receptor molecule
    • Hombach A., Wieczarkowiecz A., Marquardt T., Heuser C., Usai L., Pohl C., Seliger B., Abken H., Tumor-specific T-cell activation by recombinant immunoreceptors: CD3 signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 signaling receptor molecule Journal of Immunology 2001 167 11 6123 6131 (Pubitemid 33081538)
    • (2001) Journal of Immunology , vol.167 , Issue.11 , pp. 6123-6131
    • Hombach, A.1    Wieczarkowiecz, A.2    Marquardt, T.3    Heuser, C.4    Usai, L.5    Pohl, C.6    Seliger, B.7    Abken, H.8
  • 27
    • 33847367680 scopus 로고    scopus 로고
    • Costimulation tunes tumor-specific activation of redirected T cells in adoptive immunotherapy
    • DOI 10.1007/s00262-006-0249-0
    • Hombach A., Abken H., Costimulation tunes tumor-specific activation of redirected T-cells in adoptive immunotherapy Cancer Immunology, Immunotherapy 2007 56 5 731 737 (Pubitemid 46348741)
    • (2007) Cancer Immunology, Immunotherapy , vol.56 , Issue.5 , pp. 731-737
    • Hombach, A.1    Abken, H.2
  • 28
    • 84855186143 scopus 로고    scopus 로고
    • Costimulation by chimeric antigen receptors revisited: The T-cell antitumor response benefits from combined CD28-OX40 signalling
    • In press
    • Hombach A. A., Abken H., Costimulation by chimeric antigen receptors revisited: the T-cell antitumor response benefits from combined CD28-OX40 signalling. International Journal of Cancer. In press
    • International Journal of Cancer
    • Hombach, A.A.1    Abken, H.2
  • 29
    • 0035266137 scopus 로고    scopus 로고
    • T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis
    • Hombach A., Sent D., Schneider C., Heuser C., Koch D., Pohl C., Seliger B., Abken H., T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis Cancer Research 2001 61 5 1976 1982 (Pubitemid 32692016)
    • (2001) Cancer Research , vol.61 , Issue.5 , pp. 1976-1982
    • Hombach, A.1    Sent, D.2    Schneider, C.3    Heuser, C.4    Koch, D.5    Pohl, C.6    Seliger, B.7    Abken, H.8
  • 30
    • 33746145652 scopus 로고    scopus 로고
    • A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3ζ-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells
    • DOI 10.1136/gut.2005.076208
    • Hombach A., Schlimper C., Sievers E., Frank S., Schild H. H., Sauerbruch T., Schmidt-Wolf I. G. H., Abken H., A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3 -CD28 signalling targets T-cells from colorectal cancer patients against their tumour cells Gut 2006 55 8 1156 1164 (Pubitemid 44085685)
    • (2006) Gut , vol.55 , Issue.8 , pp. 1156-1164
    • Hombach, A.1    Schlimper, C.2    Sievers, E.3    Frank, S.4    Schild, H.H.5    Sauerbruch, T.6    Schmidt-Wolf, I.G.H.7    Abken, H.8
  • 33
    • 33947203783 scopus 로고    scopus 로고
    • + T cells in an antitumor cell attack
    • DOI 10.1158/0008-5472.CAN-06-2098
    • Koehler H., Kofler D., Hombach A., Abken H., CD28 costimulation overcomes transforming growth factor- -mediated repression of proliferation of redirected human CD4 + and CD8 + T-cells in an antitumor cell attack Cancer Research 2007 67 5 2265 2273 (Pubitemid 46424246)
    • (2007) Cancer Research , vol.67 , Issue.5 , pp. 2265-2273
    • Koehler, H.1    Kofler, D.2    Hombach, A.3    Abken, H.4
  • 34
    • 79954573204 scopus 로고    scopus 로고
    • In vivo inhibition of human CD19-targeted effector T-cells by natural T regulatory cells in a xenotransplant murine model of B-cell malignancy
    • Lee J. C., Hayman E., Pegram H. J., Santos E., Heller G., Sadelain M., Brentjens R., In vivo inhibition of human CD19-targeted effector T-cells by natural T regulatory cells in a xenotransplant murine model of B-cell malignancy Cancer Research 2011 71 8 2871 2881
    • (2011) Cancer Research , vol.71 , Issue.8 , pp. 2871-2881
    • Lee, J.C.1    Hayman, E.2    Pegram, H.J.3    Santos, E.4    Heller, G.5    Sadelain, M.6    Brentjens, R.7
  • 35
    • 79953320804 scopus 로고    scopus 로고
    • CD28 costimulation impairs the efficacy of a redirected T-cell antitumor attack in the presence of regulatory T-cells which can be overcome by preventing lck activation
    • Kofler D. M., Chmielewski M., Rappl G., Hombach A., Riet T., Schmidt A., Hombach A. A., Wendtner C.-M., Abken H., CD28 costimulation impairs the efficacy of a redirected T-cell antitumor attack in the presence of regulatory T-cells which can be overcome by preventing lck activation Molecular Therapy 2011 19 4 760 767
    • (2011) Molecular Therapy , vol.19 , Issue.4 , pp. 760-767
    • Kofler, D.M.1    Chmielewski, M.2    Rappl, G.3    Hombach, A.4    Riet, T.5    Schmidt, A.6    Hombach, A.A.7    Wendtner, C.-M.8    Abken, H.9
  • 37
    • 0033106396 scopus 로고    scopus 로고
    • Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia
    • Hallek M., Langenmayer I., Nerl C., Knauf W., Dietzfelbinger H., Adorf D., Ostwald M., Busch R., Kuhn-Hallek I., Thiel E., Emmerich B., Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia Blood 1999 93 5 1732 1737 (Pubitemid 29102502)
    • (1999) Blood , vol.93 , Issue.5 , pp. 1732-1737
    • Hallek, M.1    Langenmayer, I.2    Nerl, C.3    Knauf, W.4    Dietzfelbinger, H.5    Adorf, D.6    Ostwald, M.7    Busch, R.8    Kuhn-Hallek, I.9    Thiel, E.10    Emmerich, B.11
  • 38
    • 0347986676 scopus 로고    scopus 로고
    • Mitotic Degradation of Human Thymidine Kinase 1 Is Dependent on the Anaphase-Promoting Complex/Cyclosome - Cdh1-Mediated Pathway
    • DOI 10.1128/MCB.24.2.514-526.2004
    • Ke P.-Y., Chang Z.-F., Mitotic degradation of human thymidine kinase 1 is dependent on the anaphase-promoting complex/cyclosomeCdh1-mediated pathway Molecular and Cellular Biology 2004 24 2 514 526 (Pubitemid 38057905)
    • (2004) Molecular and Cellular Biology , vol.24 , Issue.2 , pp. 514-526
    • Ke, P.-Y.1    Chang, Z.-F.2
  • 40
    • 33845294816 scopus 로고    scopus 로고
    • CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells
    • DOI 10.1158/0008-5472.CAN-06-0160
    • Kowolik C. M., Topp M. S., Gonzalez S., Pfeiffer T., Olivares S., Gonzalez N., Smith D. D., Forman S. J., Jensen M. C., Cooper L. J. N., CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T-cells Cancer Research 2006 66 22 10995 11004 (Pubitemid 44876999)
    • (2006) Cancer Research , vol.66 , Issue.22 , pp. 10995-11004
    • Kowolik, C.M.1    Topp, M.S.2    Gonzalez, S.3    Pfeiffer, T.4    Olivares, S.5    Gonzalez, N.6    Smith, D.D.7    Forman, S.J.8    Jensen, M.C.9    Cooper, L.J.N.10
  • 43
    • 77949891071 scopus 로고    scopus 로고
    • Natural expression of the CD19 antigen impacts the long-term engraftment but not antitumor activity of CD19-specific engineered T-cells
    • Cheadle E. J., Hawkins R. E., Batha H., O'Neill A. L., Dovedi S. J., Gilham D. E., Natural expression of the CD19 antigen impacts the long-term engraftment but not antitumor activity of CD19-specific engineered T-cells Journal of Immunology 2010 184 4 1885 1896
    • (2010) Journal of Immunology , vol.184 , Issue.4 , pp. 1885-1896
    • Cheadle, E.J.1    Hawkins, R.E.2    Batha, H.3    O'Neill, A.L.4    Dovedi, S.J.5    Gilham, D.E.6
  • 47
    • 70449726875 scopus 로고    scopus 로고
    • Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts
    • Cui Y., Zhang H., Meadors J., Poon R., Guimond M., Mackall C. L., Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts Blood 2009 114 18 3831 3840
    • (2009) Blood , vol.114 , Issue.18 , pp. 3831-3840
    • Cui, Y.1    Zhang, H.2    Meadors, J.3    Poon, R.4    Guimond, M.5    MacKall, C.L.6
  • 52
    • 34547775694 scopus 로고    scopus 로고
    • Manufacturing of large numbers of patient-specific T cells for adoptive immunotherapy: An approach to improving product safety, composition, and production capacity
    • DOI 10.1097/CJI.0b013e318052e1f4, PII 0000237120070900000008
    • Tran C.-A., Burton L., Russom D., Wagner J. R., Jensen M. C., Forman S. J., DiGiusto D. L., Manufacturing of large numbers of patient-specific T-cells for adoptive immunotherapy: an approach to improving product safety, composition, and production capacity Journal of Immunotherapy 2007 30 6 644 654 (Pubitemid 47229699)
    • (2007) Journal of Immunotherapy , vol.30 , Issue.6 , pp. 644-654
    • Tran, C.-A.1    Burton, L.2    Russom, D.3    Wagner, J.R.4    Jensen, M.C.5    Forman, S.J.6    DiGiusto, D.L.7
  • 53
    • 77950480974 scopus 로고    scopus 로고
    • Treatment of chronic lymphocytic leukemia with genetically targeted autologous T-cells: Case report of an unforeseen adverse event in a phase i clinical trial
    • Brentjens R., Yeh R., Bernal Y., Riviere I., Sadelain M., Treatment of chronic lymphocytic leukemia with genetically targeted autologous T-cells: case report of an unforeseen adverse event in a phase i clinical trial Molecular Therapy 2010 18 4 666 668
    • (2010) Molecular Therapy , vol.18 , Issue.4 , pp. 666-668
    • Brentjens, R.1    Yeh, R.2    Bernal, Y.3    Riviere, I.4    Sadelain, M.5
  • 59
    • 34848818523 scopus 로고    scopus 로고
    • Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo
    • DOI 10.1007/s00262-007-0330-3
    • Lamers C. H. J., Langeveld S. C. L., Ruijven C. M. G., Debets R., Sleijfer S., Gratama J. W., Gene-modified T-cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo Cancer Immunology, Immunotherapy 2007 56 12 1875 1883 (Pubitemid 47512609)
    • (2007) Cancer Immunology, Immunotherapy , vol.56 , Issue.12 , pp. 1875-1883
    • Lamers, C.H.J.1    Langeveld, S.C.L.2    Groot-Van Ruijven, C.M.3    Debets, R.4    Sleijfer, S.5    Gratama, J.W.6
  • 61
    • 77957980319 scopus 로고    scopus 로고
    • Adoptive immunotherapy with genetically engineered T-cells: Modification of the IgG1 Fc spacer domain in the extracellular moiety of chimeric antigen receptors avoids off-target activation and unintended initiation of an innate immune response
    • Hombach A., Hombach A. A., Abken H., Adoptive immunotherapy with genetically engineered T-cells: modification of the IgG1 Fc spacer domain in the extracellular moiety of chimeric antigen receptors avoids off-target activation and unintended initiation of an innate immune response Gene Therapy 2010 17 10 1206 1213
    • (2010) Gene Therapy , vol.17 , Issue.10 , pp. 1206-1213
    • Hombach, A.1    Hombach, A.A.2    Abken, H.3
  • 65
    • 38149117105 scopus 로고    scopus 로고
    • Adoptive transfer of effector CD8 + T-cells derived from central memory cells establishes persistent T-cell memory in primates
    • Berger C., Jensen M. C., Lansdorp P. M., Gough M., Elliott C., Riddell S. R., Adoptive transfer of effector CD8 + T-cells derived from central memory cells establishes persistent T-cell memory in primates Journal of Clinical Investigation 2008 118 1 294 305
    • (2008) Journal of Clinical Investigation , vol.118 , Issue.1 , pp. 294-305
    • Berger, C.1    Jensen, M.C.2    Lansdorp, P.M.3    Gough, M.4    Elliott, C.5    Riddell, S.R.6
  • 70
    • 67549118956 scopus 로고    scopus 로고
    • Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells
    • Boissel L., Betancur M., Wels W. S., Tuncer H., Klingemann H., Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells Leukemia Research 2009 33 9 1255 1259
    • (2009) Leukemia Research , vol.33 , Issue.9 , pp. 1255-1259
    • Boissel, L.1    Betancur, M.2    Wels, W.S.3    Tuncer, H.4    Klingemann, H.5
  • 74
    • 55549129245 scopus 로고    scopus 로고
    • Progress and prospects: Zinc-finger nucleases as gene therapy agents
    • Carroll D., Progress and prospects: zinc-finger nucleases as gene therapy agents Gene Therapy 2008 15 22 1463 1468
    • (2008) Gene Therapy , vol.15 , Issue.22 , pp. 1463-1468
    • Carroll, D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.